| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |